Recent Finacing
Recent Raise
Telormedix is a clinical-stage biopharmaceutical company developing TLR7 agonist therapeutics and vaccine adjuvants—lead TMX-101 in Phase I/II for NMIBC, plus preclinical TMX-201/TMX-202 programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors